Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,153
Total Claims
$912K
Drug Cost
751
Beneficiaries
$1,215
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+225%
Opioid rate vs peers
7.3% vs 2.2% avg
-14%
Cost per patient vs peers
$1,215 vs $1,411 avg
+10%
Brand preference vs peers
11.7% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
7.3%
Opioid Rate
738
Opioid Claims
$10K
Opioid Cost
6.8%
Long-Acting Rate
Brand vs Generic
Brand: 1,174 claims · $676K
Generic: 8,844 claims · $230K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 142 | $139K |
| Rivaroxaban | 41 | $52K |
| Sacubitril/Valsartan | 26 | $32K |
| Sitagliptin Phosphate | 25 | $32K |
| Semaglutide | 21 | $31K |
| Insulin Aspart | 27 | $26K |
| Linagliptin | 23 | $25K |
| Linaclotide | 24 | $24K |
| Insulin Detemir | 36 | $23K |
| Insulin Lispro | 30 | $19K |
| Insulin Glargine,hum.Rec.Anlog | 31 | $17K |
| Fluticasone/Vilanterol | 31 | $15K |
| Budesonide/Formoterol Fumarate | 27 | $14K |
| Fluticasone/Umeclidin/Vilanter | 13 | $13K |
| Insulin Detemir | 15 | $11K |
Prescribing Profile
Patient Profile
76
Avg Age
63%
Female
2.97
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About